The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias
Rosa Paolillo 1 , Mathias Boulanger 1 , Pierre Gâtel 1 , Ludovic Gabellier 2 , Marion De Toledo 1 , Denis Tempé 1 , Rawan Hallal 1 , Dana Akl 1 , Jérôme Moreaux 3 , Hayeon Baik 1 , Elise Gueret 4 , Christian Recher 5 , Jean-Emmanuel Sarry 6 , Guillaume Cartron 7 , Marc Piechaczyk 1 , Guillaume Bossis 8
2022
Haematologica
2022 Feb 17
Abstract
10.3324/haematol.2021.279889
35172562
IGMM team(s) involved in this publication
